(RTTNews) - Royal Philips (PHG) announced the launch of Philips Ventilator BiPAP A40 EFL which comes with a new ventilation therapy feature for chronic obstructive pulmonary disease (COPD) patients to ...
Our first product, nHale™, a non-invasive ventilator, was conceived, built, and obtained Emergency Use Authorization by the FDA within 90 days to treat patients suffering from COVID-19. After ...
Studies have shown that noninvasive respiratory support at birth — rather than immediate intubation and delivery of lung surfactant — improves short-term respiratory outcomes in premature infants born ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The available ...
Connected BiPAP A40 EFL ventilator is the first to help healthcare professionals screen, detect, and abolish expiratory flow limitation to reduce work of breathing in COPD patients with abnormally ...
Noninvasive ventilation is possible in infants at limits of viability. But unlike in slightly older preterm infants, noninvasive ventilation did not show an advantage in infants of 22 weeks-0 days to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results